Abstract. The tumor suppressor p53 is widely known for its ability to induce cell cycle arrest or cell death, therefore preventing neoplastic progression. Previous studies have demonstrated novel roles for p53 in the regulation of autophagy and senescence. p53 can not only exert cell cycle-arresting and senescence-promoting or suppressing functions, but can also induce autophagic flux, particularly under conditions of nutrient deprivation. The present study demonstrated that p53 was capable of activating autophagy, which permits cell survival under conditions of serum starvation, and suppresses cellular senescence through inhibition of the mammalian target of rapamycin pathway. These results suggest that active autophagy may be a potential mechanism by which p53 suppresses cellular senescence, in response to serum starvation. The findings of the present study provide a potential mechanism for suppression of senescence by p53.
Introduction
The tumor suppressor p53, also known as the 'guardian of the cellular genome' and the 'cellular gatekeeper', is the most commonly mutated gene in human cancer (1, 2) . p53 genetic or epigenetic inactivation has been reported in ~50% of all human cancers (3) . p53 as a tumor suppressor protein, has been shown to orchestrate a transcriptional stress response that may have numerous outcomes, including cell cycle arrest and apoptosis (4) . Recent studies have identified novel functions for p53, as a regulator of diverse biological processes, including metabolism, autophagy and senescence (5) (6) (7) (8) .
Autophagy is an evolutionarily conserved catabolic process by which cytoplasmic constituents are sequestered within autophagosomes, and targeted by lysosomes for digestion (9) . Various stress signals can induce autophagy, including p53, nutrient deprivation, endoplasmic reticulum stress, hypoxia and other diverse stresses (7, 10, 11) . Autophagy may have either beneficial or detrimental cellular effects, depending on the response to environmental stresses. Increasing evidence suggests that autophagy facilitates cell survival by breaking down cytoplasmic components, in order to provide essential ingredients to maintain cellular metabolism under stressful conditions (12, 13) . However, in some cases, autophagy may contribute to cell death by extensive digestion of intracellular organelles (14) .
Cellular senescence is a process leading to irreversible arrest of the cell cycle and increased expression of β-galactosidase (β-gal) activity at pH 6. Senescence may be initiated by various insults, including telomere shortening (replicative senescence), oncogene activation, oxidative stress and DNA damage (15) . Increasing evidence has shown that cellular senescence has an important role in the control of tumor progression, and by limiting cell proliferation it acts as an anticancer barrier (16, 17) .
It has become increasingly apparent that p53 and the mammalian target of rapamycin (mTOR) pathway are critical mediators of the senescence response. p53 itself functions as either an activator or a repressor of senescence. p53 may induce senescence by activating downstream targets and preventing the block of the mTOR pathway (18) . Conversely, in some cases, p53 may negatively regulate senescence by inhibiting the mTOR pathway (19) . p53 regulation of senescence is dependent on the inverse correlation between p53 levels and mTOR activation, and both p53 and mTOR are also known for their autophagy-modulatory functions. However, it remains to be determined whether autophagic induction, in response to p53, is associated with the regulation of senescence by p53.
The present study aimed to investigate the impact of autophagy, induced by p53, on cellular senescence. p53 was p53 suppresses stress-induced cellular senescence via regulation of autophagy under the deprivation of serum shown to suppress cellular senescence through the regulation of autophagy under serum-starved conditions.
Materials and methods
Cell culture and reagents. The HCT116, human colorectal carcinoma p53 +/+ and p53 -/-cell lines were obtained from MD Anderson Cancer Center (Houston, TX, USA). All of the cell lines were maintained in McCoy's 5A media, supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin (Invitrogen Life Technologies, Carlsbad, CA, USA), and 2 mmol/l L-glutamine in a humidified atmosphere containing 95% air and 5% CO 2 . 3-Methyladenine (3-MA) was obtained from Sigma-Aldrich (St Louis, MO, USA) and was dissolved in heated sterile double distilled water, in order to produce a 400 mM stock solution. The 3-MA stock solution was then added to the media, after heating, and a final concentration of 10 mM was prepared (20, 21) . Primary rabbit anti-LC3B (1:1,000) rabbit anti-p62 (1:1,000), rabbit anti-mTOR and anti-p-mTOR (1:1,000) and rabbit p-P70S6K (1:1,000) were purchased from Cell Signaling (Beverly, MA, USA), while mouse anti-p53 (1:500) and mouse anti-GAPDH (1:1,000) were purchased from Santa Cruz (Santa Cruz, CA, USA). The green fluorescent protein (GFP)-microtubule-associated protein 1 light chain 3 B (MAP1LC3B) plasmid was obtained from OriGene Technologies, Inc. (Rockville, MD, USA). Acridine orange solution (AO) was purchased from Sigma-Aldrich.
Measurement of cell viability. Cell viability was determined by MTT assay (Sigma-Aldrich), light microscopy (Olympus, Tokyo, Japan) and crystal violet staining (Sigma-Aldrich).
Cell cycle analysis. A f luorescence activated cell sorting-assisted cell cycle analysis, for DNA content, was performed using the Cycletest™ Plus DNA Reagent kit (BD Biosciences, Franklin Lakes, NJ, USA), according to the manufacturer's instructions.
Detection of autophagy.
To detect the presence of acidic vesicular organelles (AVO), the cells were stained for 24 h with the AO vital dye (1 µg/ml) and examined under a fluorescence microscope. GFP-MAP1LC3B transient transfection was performed according to the supplier's instructions. Briefly, sterile 12 mm cover slides were seeded with 5x10 5 cells into 6-well plates. After attachment overnight, cells were washed twice with phosphate-buffered saline (PBS) and the medium was replaced by serum-free medium for 24 h and then the cells were transiently transfected with a GFP-LC3B expressing vector (Origene, MD, USA). After 32 h of exposure to treatment, cells were washed with cold PBS and then fixed with 4% formaldehyde in PBS (pH 7.4) for 20 min at room temperature.
β-gal staining. β-gal staining was performed using the Senescence-Galactosidase Staining kit (Cell Signaling Technology). After serum starvation for 24 h, the cells were washed twice with PBS and then fixed with PBS containing 2% formaldehyde (Shanghai Biological Technology, Shanghai, China) and 0.2% glutaraldehyde (Shanghai Biological Technology) for 10 min. The cells were then incubated at 37ºC (NO CO 2 ) for 10 h with staining solution (40 mM citric acid sodium phosphate, pH 6.0, 1 mg/ml 5-bromo-4-chloro-3-isolyl-B-D-galactoside [X-gal, Fisher, Pittsburgh, PA], 5 mM potassium ferricyanide, 150 mM NaCl, 2 mM MgCl 2 ). After being washed twice with PBS, the cells were incubated with 4' , 6-diamidino-2-phenlindole dihydrochloride (DAPI, 1 ug/ml, DOJINDO, Tokyo, Japan) at 4˚C for 2 h. SA-B-gal-positive cells were enumerated by counting over 400 cells in three independent fields.
Western blotting. The cells were harvested from the 10 cm culture dishes via centrifugation (800 x g for 30 min at 4˚C) and lysed in lysis buffer (20 mM Tris-HCl, pH 7.6; 1 mM EDTA; 140 mM NaCl; 1% NP-40; 1% aprotinin; 1 mM phenylmethylsulfonyl fluoride; 1 mM sodium vanadate). The protein concentrations were determined using a Bicinchoninic Acid Protein Assay kit (Pierce Biotechnology, Inc., Rockford, IL, USA). The cell lysates (40 µg protein/lane) were loaded onto 5-20% Tris-Tricine Ready SDS-PAGE gels (Bio-Rad Laboratories, Inc., Hercules, CA, USA), separated by electrophoresis, and transferred to nitrocellulose membranes (Shanghai ZDAN International, Shanghai, China). The blotted membranes were blocked with 5% skim milk for 1 h and were then incubated with the primary antibodies for 2 h at 37˚C. The immunoreactive bands were visualized by enhanced chemiluminescence (Pierce, Rockford, IL, USA), following a further incubation with horseradish peroxidase-conjugated immunoglobulin G secondary antibodies. The band density was determined by densitometry, and quantified using gel plotting macros of National Institutes of Health (NIH) Image 1.62, (NIH, Bethesda, MA, USA).
Cell cycle analysis. Cell cycle distribution was determined by flow cytometry. Briefly, a total of 1-2×10 6 cells were cultured in medium containing 10% FBS. Serum was withdrawn from culture medium when cells were 70% confluent. After 72 h, 10% FBS was added to the medium for an additional 12 h. Cells were fixed in 70% ethanol and stained with propidium iodide (BD Pharmingen, San Jose, CA) and DNA content was analysed by FACSCalibur Flow Cytometer (BD Biosystems, Heidelberg, Germany). stains AVOs, including autophagic vacuoles. An increase in the intensity of AVOs was observed by fluorescent microscopy in the HCT116 p53 +/+ cells following serum starvation, however few AVOs were detected in the HCT116 p53 −/− cells (Fig. 1A) . These results indicate that p53 may activate autophagy under serum starvation. Furthermore, autophagic flux induced by p53 was attenuated by treatment with 10 mmol/l 3-MA (Fig. 1A) . For further confirmation, the HCT116 cells were transiently transfected with a GFP-MAP1LC3B plasmid. MAP1LC3B is a key component of the autophagosomal membrane, and is associated with autophagosome generation (22) . Upon induction of autophagy, punctate fluorescence of GFP-MAP1LC3B can be observed. Punctate fluorescence was markedly evident in the HCT116 p53 +/+ cells, as compared with the p53 −/− cells, following serum starvation, and this fluorescence was effectively inhibited by 3-MA (Fig. 1B) . These results further imply that p53 is capable of activating autophagy under serum-starved conditions. In addition, the western blot analysis (Fig. 1C) detected a significantly increased LC3-II/I ratio, and decreased abundance of p62 in the p53 +/+ cells, as compared with the p53 −/− cells following serum starvation. These data indicate that p53 promotes autophagy and suggest that p53 may induce autophagy under serum-starved conditions. It is well known that p53 can promote apoptosis under normal conditions (Fig. 2) ; however, the present study aimed to determine whether p53 could still induce apoptosis in response to serum starvation. The impact of autophagy, induced by p53 under serum starvation, was assessed on cell survival using an MTT assay, light microscopy and crystal violet staining. Notably, more viable cells were detected in the HCT116 p53 +/+ group as compared with the HCT116 p53 −/− group following serum starvation for 24 h ( Fig. 2A-C) . These results imply that p53 may facilitate cellular survival in response to serum starvation. To determine whether p53-dependent autophagic regulation protects cancer cells from starvation-induced death, cell viability was determined in both HCT116 p53 +/+ and p53 −/− cells following serum starvation, in the presence of 3-MA.
A large number of apoptotic cells were present in the p53 +/+ group following treatment with 3-MA, as determined by flow cytometry; however, no significant changes were observed in the apoptosis of the p53 −/− cells (Fig. 2C) . These results indicate that p53-dependent autophagic regulation maintains HCT116 p53 +/+ cell survival under conditions of serum starvation.
p53 suppresses stress-induced senescence and simultaneously causes quiescence in HCT116 cancer cells. Cellular senescence is a process that leads to the irreversible loss of proliferative potential, and permanent growth arrest. Quiescence is significantly different to senescence, as it results in a stable but reversible growth arrest (23) . Previous A B studies have suggested that p53 promotes senescence, by p53-induced cell cycle arrest (15, 16, 24) . Furthermore, p53, as a transcriptional regulator, may induce transcription of cyclin-dependent kinase inhibitor p21, which is upregulated in numerous cell lines during senescence and cell cycle arrest (25, 26) . However, recent studies have shown that p53 may also negatively regulate senescence (19, 23, 27) . Therefore, the effects of p53 on the starvation-induced cell cycle were assessed in the present study, by propidium iodide staining and subsequent flow cytometric analysis. p53 inhibited the G 1 -to-S transitions: G 1 /S 13.08 in p53 +/+ cells, as compared with only 6.33 in p53 −/− cells (Fig. 3A) . These results demonstrate that p53 may promote starvation-induced cell cycle arrest. Western blotting showed that the expression of p21 was suppressed, and the protein expression levels of cyclin B were enhanced in the starved HCT116 p53 −/− cells, as compared with the p53 +/+ cells (Fig. 3B) , thus implying that p53 inhibits starvation-induced cell cycle progression. These data suggest that p53 may induce cell cycle arrest in response to serum starvation, thus resulting in cell quiescence.
To confirm the role of p53 in cellular senescence in response to serum starvation, staining with β-gal was conducted. β-gal is a well-known marker present only in senescent cells, but not in pre-senescent, quiescent or immortal cells. β-gal activity was significantly increased in the serum-starved HCT116 p53
−/− cells, as compared with the serum-starved HCT116 p53 +/+ cells (Fig. 4A) , suggesting that p53 may function as a suppressor of cellular senescence, in response to serum starvation. These data suggest that although p53 induces the expression of p21 and causes cell cycle arrest in the absence of serum, p53 simultaneously suppresses, rather than promotes stress-induced senescence.
p53 suppresses cellular senescence through regulation of autophagy. In the absence of serum, p53 may activate autophagic flux, which can be attenuated by treatment with 3-MA. The present study aimed to determine whether inhibition of p53-dependent autophagy may promote cellular senescence. Both starved HCT116 p53 +/+ and p53 −/− cells were treated with 3-MA. β-gal activity was markedly enhanced in the starved HCT116 p53 +/+ cells in response to 3-MA treatment, but hardly changed in the starved p53 −/− cells (Fig. 4A) . These results indicate that inhibition of p53-dependent autophagy may promote cellular senescence.
To determine the potential mechanisms by which p53-dependent autophagy suppresses senescence, the impact of autophagy induced by p53 was observed on the mTOR pathway, which is a contributor to cellular senescence. mTOR acts as a key regulator during cellular processes such as cell-cycle progression, anabolism, autophagy and senescence (28) . The maintenance of mTOR signaling under conditions of cell cycle arrest may lead to senescence, whereas inhibition of mTOR by rapamycin converts senescence into quiescence (29) . Another response to mTOR inhibition is the induction of autophagy, which allows cell survival under conditions of nutrient deprivation. p53 is able to inhibit the mTOR pathway through a number of known p53 transcriptional targets, including AMP-activated protein kinase, tuberous sclerosis complex 2, phosphatase and tensin homolog (PTEN), and sestrins, all of which are upstream negative regulators of the mTOR pathway (30,31) . Therefore, the present study examined whether p53-dependent autophagy was capable of suppressing senescence through the inhibition of mTOR. The expression levels of mTOR, phospho-mTOR and phospho-P70S6K were determined. Under the deprivation of serum, mTOR and P70S6K phosphorylation were significantly inhibited in the HCT116 p53 +/+ cells ( Fig. 4A and B) . These results suggest that suppression of senescence through p53-dependent autophagy may occur partly through the inhibition of the mTOR pathway.
Discussion
Previous studies have implicated p53 in the promotion of senescence; however, a controversial role of p53 in the regulation of senescence has emerged in recent studies (8) (9) (10) (11) (12) (13) (14) (15) . p53 has been shown to inhibit senescence, while promoting cell cycle arrest (19) . The subsequent fate of the arrested cells is considered to be dependent on p53-associated regulation of the mTOR pathway; active mTOR leads to senescence, whereas inhibition of mTOR suppresses senescence and leads to quiescence (27, 29) .
Despite the conflicting evidence regarding the ability of p53 to enhance or inhibit autophagy (32) , the present study showed that p53 may promote autophagic flux, in response to serum starvation. Active autophagy allows cells to break down long-lived proteins and organelles, thus providing metabolites and ATP that may be used for cell survival, in order to cope with diverse environmental stresses (12) . Furthermore, autophagy induced by p53 may be inhibited through enhancement of mTOR signaling, resulting in a marked increase in the levels of cell death in the starved HCT116 p53 +/+ cells, following treatment with 3-MA.
The principal role of p53 is to promote p21-dependent cell cycle arrest; however, subsequent overexpression of p21 can not induce senescence since the transcriptional level of p21 is abrogated in senescent HCT116 p53 −/− cells. This implies that p21 is not the determinant of cellular senescence. The present study determined the expression levels of PTEN, a negative regulator of the mTOR pathway. The results demonstrated that activation of mTOR is required for induction of senescence, not p21.
p53 has previously been shown to be capable of inhibiting the mTOR pathway at numerous levels in response to stress (30, 33) , and mTOR inhibition may promote autophagy and suppress cellular senescence. However, there is little knowledge regarding p53-induced autophagy and its involvement in cellular senescence. Therefore, the present study tested the hypothesis that inhibition of autophagy by 3-MA treatment contributed to cellular senescence. 3-MA is an inhibitor of phosphatidylinositol 3-kinase and is widely used to suppress autophagy. In agreement with the hypothesis, p53 suppressed cellular senescence under serum starvation conditions, which may be attributed to active autophagy induced by p53 (11) . In the presence of 3-MA, senescent morphologies were evident in the starved HCT116 p53 +/+ cells, implying that suppression of senescence by p53 may be associated with the regulation of p53-dependent autophagy. Furthermore, this phenomenon may be explained by the regulation of the mTOR pathway.
In conclusion, the results of the present study suggest that, in response to serum starvation, p53 activates autophagic flux and subsequent autophagy functions as a survival pathway, in order to suppress cellular senescence by regulation of the mTOR pathway. This provides a potential association between autophagy and senescence and explains why p53 may suppress cellular senescence in response to starvation.
